Barclays Maintains Overweight on MasTec, Lowers Price Target to $106
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Adam Seiden maintains an Overweight rating on MasTec (NYSE:MTZ) but lowers the price target from $120 to $106.

October 18, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays maintains an Overweight rating on MasTec but lowers the price target from $120 to $106.
While Barclays maintains an Overweight rating on MasTec, indicating a positive outlook, the lowering of the price target from $120 to $106 could create some uncertainty among investors. This might lead to short-term volatility in the stock price, but the overall impact is neutral as the rating remains positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100